The majority of patients in our sample exhibited anemia (median hemoglobin 10.7 g/dL), thrombocytopenia (median platelets 74 × 103/μL), and elevated liver function tests (median alanine aminotransferase (ALT) 59 U/L, median aspartate aminotransferase (AST) 79 U/L, median total bilirubin 1.3 mg/dL). This evidence concerns the gene GPT and anemia.